Clinical manifestation of targeted drugs in individualized therapy of malignant tumors.
- Author:
Da-tong CHU
- Publication Type:Journal Article
- MeSH:
Antibodies, Monoclonal, Murine-Derived;
therapeutic use;
Antineoplastic Agents;
therapeutic use;
Antineoplastic Combined Chemotherapy Protocols;
therapeutic use;
Benzamides;
Cyclophosphamide;
therapeutic use;
Doxorubicin;
therapeutic use;
Drug Delivery Systems;
methods;
Gastrointestinal Stromal Tumors;
drug therapy;
Humans;
Imatinib Mesylate;
Indoles;
therapeutic use;
Leukemia, Lymphocytic, Chronic, B-Cell;
drug therapy;
Leukemia, Myeloid;
drug therapy;
Lymphoma, Large B-Cell, Diffuse;
drug therapy;
Mutation;
Neoplasms;
drug therapy;
genetics;
metabolism;
Piperazines;
therapeutic use;
Prednisone;
therapeutic use;
Pyrimidines;
therapeutic use;
Pyrroles;
therapeutic use;
Receptor, Epidermal Growth Factor;
genetics;
metabolism;
Remission Induction;
Rituximab;
Vincristine;
therapeutic use
- From:
Chinese Journal of Oncology
2010;32(10):721-724
- CountryChina
- Language:Chinese
